Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Mirati Therapeutics Inc. buy DomRuinart

Mirati Therapeutics Inc.
Start price
€138.00
16.06.21 / 50%
Target price
€200.00
16.06.22
Performance (%)
6.20%
End price
€146.55
28.06.21
Summary
This prediction ended on 28.06.21 with a price of €146.55. With a performance of 6.20%, the BUY prediction by DomRuinart for Mirati Therapeutics Inc. closed with a slight gain. DomRuinart has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Mirati Therapeutics Inc. - - -
iShares Core DAX® 0.597% 3.083% 16.090%
iShares Nasdaq 100 0.899% 5.338% 29.239%
iShares Nikkei 225® 1.775% -1.206% 6.823%
iShares S&P 500 0.990% 3.500% 24.956%

According to DomRuinart what are the pros and cons of Mirati Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by DomRuinart for this prediction

In the thread Mirati Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 6.20%
Target price 200.000
Change
Ends at 16.06.22

Buy mit Kursziel 200,0

DomRuinart 
0
Report Share
16.06.21
In the thread Trading Mirati Therapeutics Inc.
Prediction Buy
Perf. (%) 6.20%
Target price 200.000
Change
Ends at 16.06.22

Buy beendet

DomRuinart 
0
Report Share
28.06.21

Stopped prediction by DomRuinart for Mirati Therapeutics Inc.

buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€146.55
28.06.21
€200.00
28.06.22
-3.62%
12.07.21

Could be worthwhile Investment >10% per year
DomRuinart 
28.06.21 50%